Lamotrigine
NDC 0228-1435 · Actavis Pharma, Inc.
FDA lists marketing as ended on 2026-08-31.
Generic nameLamotrigine
Dosage formTABLET, FILM COATED, EXTENDED RELEASE
RouteORAL
Active ingredient(s)LAMOTRIGINE
Strength50 mg/1
Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
Marketing categoryANDA
Packages
0228-1435-03 — 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-1435-03)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0173-0756 — lamotrigine, 0173-0757 — lamotrigine, 0173-0761 — lamotrigine, 0173-0772 — lamotrigine, 0173-0774 — lamotrigine, 0173-0776 — lamotrigine, 0173-0777 — lamotrigine, 0173-0781 — lamotrigine, 0228-1410 — Lamotrigine, 0228-1422 — Lamotrigine, 0228-1453 — Lamotrigine, 0228-1580 — Lamotrigine, 0228-1638 — Lamotrigine, 0615-7964 — Lamotrigine, 0615-7975 — Lamotrigine, 0615-8150 — Lamotrigine, 0615-8267 — Lamotrigine, 0904-7007 — Lamotrigine, 0904-7008 — Lamotrigine, 10370-207 — lamotrigine, +270 more